PortfoliosLab logoPortfoliosLab logo
JEDG.L vs. BTEK.L
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

JEDG.L vs. BTEK.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in VanEck Space Innovators UCITS ETF (JEDG.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JEDG.L achieves a 74.89% return, which is significantly higher than BTEK.L's 4.86% return.


JEDG.L

1D
1.49%
1M
23.72%
YTD
74.89%
6M
96.65%
1Y
211.91%
3Y*
65.85%
5Y*
10Y*

BTEK.L

1D
3.56%
1M
2.25%
YTD
4.86%
6M
2.70%
1Y
43.15%
3Y*
10.19%
5Y*
5.85%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

JEDG.L vs. BTEK.L - Yearly Performance Comparison


2026 (YTD)2025202420232022
JEDG.L
VanEck Space Innovators UCITS ETF
74.89%80.38%46.13%6.44%-12.08%
BTEK.L
iShares Nasdaq US Biotechnology UCITS ETF
4.86%23.81%-0.32%0.33%11.00%

Correlation

The correlation between JEDG.L and BTEK.L is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jun 28, 2022

0.37

The correlation between JEDG.L and BTEK.L shifts across timeframes, from 0.27 (1 year) to 0.37 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JEDG.L vs. BTEK.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JEDG.L
JEDG.L Risk / Return Rank: 9595
Overall Rank
JEDG.L Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
JEDG.L Sortino Ratio Rank: 9494
Sortino Ratio Rank
JEDG.L Omega Ratio Rank: 9292
Omega Ratio Rank
JEDG.L Calmar Ratio Rank: 9696
Calmar Ratio Rank
JEDG.L Martin Ratio Rank: 9595
Martin Ratio Rank

BTEK.L
BTEK.L Risk / Return Rank: 7676
Overall Rank
BTEK.L Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
BTEK.L Sortino Ratio Rank: 7070
Sortino Ratio Rank
BTEK.L Omega Ratio Rank: 6363
Omega Ratio Rank
BTEK.L Calmar Ratio Rank: 9292
Calmar Ratio Rank
BTEK.L Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JEDG.L vs. BTEK.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Space Innovators UCITS ETF (JEDG.L) and iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JEDG.LBTEK.LDifference
Sharpe ratioReturn per unit of total volatility

+2.52

Sortino ratioReturn per unit of downside risk

+1.64

Omega ratioGain probability vs. loss probability

1.61

1.38

+0.23

Calmar ratioReturn relative to maximum drawdown

9.18

6.23

+2.95

Martin ratioReturn relative to average drawdown

30.71

17.55

+13.15

JEDG.L vs. BTEK.L - Sharpe Ratio Comparison

The current JEDG.L Sharpe Ratio is 4.77, which is higher than the BTEK.L Sharpe Ratio of 2.24. The chart below compares the historical Sharpe Ratios of JEDG.L and BTEK.L, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JEDG.LBTEK.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

4.77

2.24

+2.52

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

1.36

0.31

+1.05

Drawdowns

JEDG.L vs. BTEK.L - Drawdown Comparison

The maximum JEDG.L drawdown since its inception was -26.80%, smaller than the maximum BTEK.L drawdown of -30.86%. Use the drawdown chart below to compare losses from any high point for JEDG.L and BTEK.L.


Loading charts...

Drawdown Indicators


JEDG.LBTEK.LDifference

Max Drawdown

Largest peak-to-trough decline

-26.80%

-30.86%

+4.06%

Max Drawdown (1Y)

Largest decline over 1 year

-22.94%

-6.89%

-16.05%

Max Drawdown (3Y)

Largest decline over 3 years

-26.80%

-26.34%

-0.46%

Max Drawdown (5Y)

Largest decline over 5 years

-30.86%

Current Drawdown

Current decline from peak

-13.90%

-1.86%

-12.04%

Average Drawdown

Average peak-to-trough decline

-8.86%

-10.04%

+1.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.87%

2.45%

+4.42%

Volatility

JEDG.L vs. BTEK.L - Volatility Comparison

VanEck Space Innovators UCITS ETF (JEDG.L) has a higher volatility of 18.94% compared to iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) at 6.91%. This indicates that JEDG.L's price experiences larger fluctuations and is considered to be riskier than BTEK.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JEDG.LBTEK.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.94%

6.91%

+12.03%

Volatility (6M)

Calculated over the trailing 6-month period

34.54%

14.67%

+19.87%

Volatility (1Y)

Calculated over the trailing 1-year period

44.16%

19.14%

+25.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.12%

20.08%

+13.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.12%

21.71%

+11.41%

JEDG.L vs. BTEK.L - Expense Ratio Comparison

JEDG.L has a 0.55% expense ratio, which is higher than BTEK.L's 0.35% expense ratio.


Dividends

JEDG.L vs. BTEK.L - Dividend Comparison

Neither JEDG.L nor BTEK.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


JEDG.L and BTEK.L have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, BTEK.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

BTEK.L is cheaper with a 0.35% expense ratio, compared with 0.55% for JEDG.L.

JEDG.L is categorized as Industrials Equities, while BTEK.L is Health & Biotech Equities. JEDG.L tracks MSCI World/Materials NR USD, while BTEK.L tracks NASDAQ Biotechnology TR USD. They also come from different issuers: VanEck and iShares. Their fees differ too: 0.55% for JEDG.L and 0.35% for BTEK.L.

Portfolio Optimizer

Find the right allocation for JEDG.L and BTEK.L

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer